CD8A and neoplasm: Because of the induction of ICD in tumor tissues, this probe could robustly induce an anti-tumor immune response by enhancing the number of CD8+ tumor-infiltrating T lymphocytes in the TME, showing good immune antitumor efficacy for tumor inhibition.